BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38624201)

  • 1. Transrectal versus transperineal prostate biopsy for cancer detection in patients with gray-zone prostate-specific antigen: a multicenter, real-world study.
    Liu JX; Wang ZY; Niu SX; Sai XY; Zhang X; Zhang XP; Ma X
    Asian J Androl; 2024 Apr; ():. PubMed ID: 38624201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effective transperineal prostate biopsy method utilizes the original transrectal setting.
    Wu RC; Tung MC; Wu CH; Mai HC; Huang WL; Chen SH; Lin VC
    Int Urol Nephrol; 2023 Nov; 55(11):2695-2701. PubMed ID: 37505427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates.
    Hogenhout R; Remmers S; van Leenders GJLH; Roobol MJ
    Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):581-587. PubMed ID: 36631536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer detection and complications of transperineal prostate biopsy with antibiotics when indicated.
    Boevé LMS; Bloemendal FT; de Bie KCC; van Haarst EP; Krul EJT; de Bruijn JJ; Beems S; Vanhommerig JW; Hovius MC; Ruiter AEC; Lagerveld BW; van Andel G
    BJU Int; 2023 Oct; 132(4):397-403. PubMed ID: 37155185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review.
    Rai BP; Mayerhofer C; Somani BK; Kallidonis P; Nagele U; Tokas T
    Eur Urol Oncol; 2021 Dec; 4(6):904-913. PubMed ID: 33478936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
    Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
    J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
    [No Abstract]   [Full Text] [Related]  

  • 8. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.
    Ong WL; Weerakoon M; Huang S; Paul E; Lawrentschuk N; Frydenberg M; Moon D; Murphy D; Grummet J
    BJU Int; 2015 Oct; 116(4):568-76. PubMed ID: 25560926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are outpatient transperineal prostate biopsies without antibiotic prophylaxis equivalent to standard transrectal biopsies for patient safety and cancer detection rates?A retrospective cohort study in 222 patients.
    Islam M; Da Silva RD; Quach A; Gustafson D; Nogueira L; Clark N; Kim FJ
    Patient Saf Surg; 2021 Aug; 15(1):28. PubMed ID: 34419137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
    Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
    Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
    Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
    [No Abstract]   [Full Text] [Related]  

  • 12. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison.
    Kaneko M; Medina LG; Lenon MSL; Hemal S; Sayegh AS; Jadvar DS; Ramacciotti LS; Paralkar D; Cacciamani GE; Lebastchi AH; Salhia B; Aron M; Hopstone M; Duddalwar V; Palmer SL; Gill IS; Abreu AL
    Sci Rep; 2023 Aug; 13(1):13457. PubMed ID: 37596374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
    Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transperineal and transrectal targeted prostate biopsy using Mahalanobis distance matching within propensity score caliper method: A multicenter study of Turkish Urooncology Association.
    Koparal MY; Sözen TS; Karşıyakalı N; Aslan G; Akdoğan B; Şahin B; Türkeri L;
    Prostate; 2022 Mar; 82(4):425-432. PubMed ID: 34927740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.
    Watanabe M; Hayashi T; Tsushima T; Irie S; Kaneshige T; Kumon H
    Int J Urol; 2005 Nov; 12(11):959-63. PubMed ID: 16351651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A propensity score matching analysis.
    Byun HJ; Shin TJ; Jung W; Ha JY; Kim BH; Kim YH
    Prostate Int; 2022 Mar; 10(1):45-49. PubMed ID: 35510102
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang J; Li J; Xiao L; Zhou M; Fang Z; Cai Y; Tang Y; Hu S
    Cancer Imaging; 2023 Sep; 23(1):81. PubMed ID: 37667341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.
    Sidana A; Watson MJ; George AK; Rastinehad AR; Vourganti S; Rais-Bahrami S; Muthigi A; Maruf M; Gordetsky JB; Nix JW; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
    Urol Oncol; 2018 Jul; 36(7):341.e1-341.e7. PubMed ID: 29753548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.